Skip to main content
Sandra Sobel, MD, Endocrinology, Pittsburgh, PA, UPMC Presbyterian Shadyside

SandraIndacocheaSobelMD

Endocrinology Pittsburgh, PA

Diabetes, Lipid Metabolism

Endocrinologist, Lifestyle Medicine, and Obesity Medicine Physician CEO, Summon Health www.summonhealth.com

Dr. Sobel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sobel's full profile

Already have an account?

Summary

  • Summon Health is an innovative direct care endocrine medical practice that integrates cutting-edge health technologies with nutrition consulting, exercise, and stress-reduction, tailored specifically to you. This comprehensive and evidence-based medical approach helps activate metabolism and prevent, manage, or even reverse metabolic disease. www.summonhealth.com

    I am a board certified Internal Medicine, Diabetes, Endocrinology, & Metabolism, Lifestyle Medicine, and Obesity Medicine Physician. I earned my medical degree from the University of Chicago Pritzker School of Medicine, completed intern year of Internal Medicine residency at New York Presbyterian – Columbia Hospital in New York City, and my final two years of residency at Loyola University Medical Center in Chicago. I completed my fellowship in Endocrinology at the University of Pittsburgh.

    I served as faculty at the University of Pittsburgh Medical Center in the Division of Diabetes, Endocrinology, and Metabolism for 7 years and as Clinical Chief of Endocrinology at UPMC Mercy during all those years. I have received multiple institutional grants that funded my clinical research interests in the delivery of diabetes care using diabetes technology. My specific clinical interests are in type 1 diabetes management; type 2 diabetes management, prevention, and reversal; obesity management, prevention, and reversal; and other conditions of insulin resistance such as metabolic syndrome, pre-diabetes, overweight, and fatty liver disease.
  • Summon Health Webpage

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013
  • Loyola University Medical Center
    Loyola University Medical CenterResidency, Internal Medicine, 2008 - 2010
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2007 - 2010
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2022 - 2025
  • FL State Medical License
    FL State Medical License 2022 - 2025
  • IN State Medical License
    IN State Medical License 2022 - 2025
  • MD State Medical License
    MD State Medical License 2022 - 2025
  • NY State Medical License
    NY State Medical License 2022 - 2024
  • PA State Medical License
    PA State Medical License 2010 - 2024
  • OH State Medical License
    OH State Medical License 2022 - 2024
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • American Board of Obesity Medicine Obesity Medicine
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • SGLT2 Inhibitors May Lower the Risk of Major Cardiovascular Events
    SGLT2 Inhibitors May Lower the Risk of Major Cardiovascular EventsOctober 1st, 2020
  • New Device Represents Breakthrough in Type 1 Diabetes Management
    New Device Represents Breakthrough in Type 1 Diabetes ManagementOctober 25th, 2016

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations